IVIM Health vs Luvo Health: Ratings, Pricing, and Protocols Compared

Quick verdict: IVIM Health is the clearer choice for people who value third-party ratings, published observational data, and transparent starting prices; Luvo Health offers clinician-reviewed programs with ongoing support but captured pricing and details were not verified.

Explore IVIM Health’s free month offer

IVIM Health vs Luvo Health: snapshot comparison

This comparison focuses on the most distinctive supported differences: third-party ratings and trust signals, pricing transparency and promotions, protocol and clinical evidence claims, medication types and formulation notes, and the availability or verification of program details. The primary keyword IVIM Health vs Luvo Health appears here to guide readers deciding between these two clinician-reviewed weight-management options.

1. Third-party ratings and trust signals

IVIM Health: Documented 4.9-star ratings on both Google and Trustpilot, described as an unusually strong satisfaction signal. Luvo Health: Not verified on the captured landing-page evidence; the source did not publish third-party rating details.

See IVIM Health reviews and ratings

2. Pricing transparency and promotions

IVIM Health supplies concrete starting prices and promotions: listed prices include semaglutide at $75/mo and tirzepatide at $133/mo plus a $74.99/mo program fee, with a Limited Offer free month membership using code GIFT75 and a no-obligation free consultation valued at $75. The FAQ captured states IVIM starts at $99 for the first month and $174/month ongoing, and new patients can use the GIFT75 free-month code. Luvo Health: captured landing-page evidence did not verify specific starting prices; the page notes MONTH 1, MONTH 2-3, and 3+ months pricing structure in principle but current details were not published or could not be verified.

Check Luvo Health program availability

3. Protocol claims and clinical evidence

IVIM Health: Promotes GLP-1 ID, a proprietary clinician-guided titration and optimization protocol that IVIM says can accelerate weight loss outcomes by up to 40% compared to standard GLP-1 protocols. IVIM also cites two peer-reviewed retrospective observational studies published in Obesity Pillars examining semaglutide and tirzepatide outcomes across branded and compounded formulations. IVIM notes these are independent retrospective studies and not randomized head-to-head trials, and results may vary. Luvo Health: The captured page emphasizes clinician-reviewed treatment with dose adjustments based on clinical response, ongoing support, and cancel anytime policies, but did not capture independent clinical claims or published outcome studies.

4. Medication types and compounded status

Both providers reference compounded formulations in the captured evidence. IVIM explicitly states compounded semaglutide and tirzepatide are offered and repeatedly warns that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Luvo Health’s captured evidence also notes that compounded medications are prepared by licensed pharmacies and are not reviewed or approved by the FDA. IVIM additionally calls out that medications are prepared by independent, licensed compounding pharmacies and that actual product appearance may differ from images shown.

5. Availability, verification, and what is not supplied

IVIM Health: Capture includes specific program fees, promotions, and state availability notes that say not available in all states. Luvo Health: The captured landing-page evidence repeatedly states that current details were not published or could not be verified and advises people to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment. The Luvo source did not provide expanded FAQ answers or concrete pricing in the captured evidence.

Criteria	IVIM Health	Luvo Health
Third-party ratings	4.9 stars on Google and Trustpilot	Not verified in captured evidence
Pricing transparency	Starting prices listed; GIFT75 free month and free $75 consult	Pricing structure shown but current details not published or verified
Protocol or studies	Proprietary GLP-1 ID protocol; two retrospective observational studies cited	Ongoing support and dose adjustments; no published studies captured
Medication types	Compounded semaglutide and tirzepatide noted	Offers tirzepatide and semaglutide forms; compounded meds noted
Regulatory note	Compounded meds are not FDA-approved; explicit warnings provided	Compounded meds are not reviewed by FDA; warning included
State availability and verification	Not available in all states; details provided	Advises confirming eligibility and state availability; specifics not verified

How to decide: IVIM Health vs Luvo Health

Use the comparison above to match your priorities. If third-party ratings, transparent published starting prices, and cited observational studies matter most, IVIM Health provides those documented signals in the captured evidence. If you need a clinician-reviewed program with ongoing dose adjustments but require confirmation of current pricing and eligibility first, the Luvo Health landing evidence directs you to verify those details before enrolling.

Start IVIM Health consultation

Contact Luvo Health to confirm details

Final guidance

Choose IVIM Health if you prioritize documented third-party satisfaction, clear starting prices and membership promotions like the GIFT75 free month, and a proprietary protocol backed by retrospective observational studies. Choose Luvo Health if you want a clinician-reviewed program that emphasizes ongoing support and dose adjustments but are prepared to confirm pricing, eligibility, pharmacy, and state availability because those specifics were not verified in the captured evidence.